Jessica Cheng Poster.pptx

Oral Vitamin K Prophylaxis to Prevent Vitamin K Deficiency in Newborns: A Survey of Clinician Opinions and Practices

Jessica Cheng, MD, Jaspreet Loyal, MD, MS, Kelly Wood, MD, Laura R. Kair, MD, MAS

Oral Presentation

Jessica Cheng Oral Presentation.m4a

Background: The vast majority of newborns in the United States (US) receive intramuscular (IM) vitamin K for prophylaxis against vitamin K deficiency bleeding (VKDB), a serious and life-threatening bleeding condition. Oral vitamin K is not as effective as IM vitamin K in preventing VKDB but is widely used in Europe and by an increasing number of US parents who refuse IM vitamin K for their newborn.

Objective: To assess the opinions and practices of newborn clinicians regarding oral vitamin K prophylaxis against VKDB when parents refuse IM vitamin K.

Methods: Newborn clinicians from 3 academic medical centers in California, Iowa and Connecticut were invited to participate in an electronic cross-sectional survey. The survey was created following literature review and expert opinion. We asked participants about their opinions, practices, and knowledge regarding oral vitamin K and compared responses from clinicians in the neonatal intensive care unit (NICU) and the well-newborn nursery. Descriptive statistics and one-way ANOVA analyses were performed.

Results: Of 160 newborn clinicians at 3 sites, 105 (66%) completed the survey. Of respondents, 56 (56%) believed that the incidence of IM vitamin K refusal is increasing and had prescribed or recommended oral vitamin K at least once. Of prescribed formulations, liquid was most common (78%) followed by crushed tablets (13%). Regarding knowledge, 28 (28%) and 21 (21%) respondents did not know if oral vitamin K decreases the risk of early- and late-onset VKDB, respectively. There were no significant differences among institutions or practice setting (NICU, well-newborn nursery or both) with regards to opinions, practices, and knowledge. The most common reasons given for prescribing oral vitamin K were that it is better than no prophylaxis and parental preference. The most common reasons given for not prescribing oral vitamin K were concerns for efficacy, poor compliance, and lack of encounters with parents that have refused IM vitamin K.

Conclusions: Over half of the clinicians surveyed had prescribed oral vitamin K to newborns as prophylaxis against VKDB. For some respondents, knowledge was lacking regarding the efficacy of oral vitamin K in early- and late-onset VKDB. Clinicians need to be prepared to counsel parents about VKDB and the effectiveness of IM versus oral vitamin K prophylaxis in preventing VKDB. Additional data is needed regarding currently prescribed oral vitamin K regimens.

Resident Statement of Involvement: I helped conceived of the idea, obtained IRB approval, designed the survey, aggregated results, performed data analysis, and was first author on the published manuscript.